FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Multiple Violations at Invitrx Therapeutics

[ Price : $8.95]

FDA warns Lake Forest, CA-based Invitrx Therapeutics about illegally marketing cellular and acellular products and CGMP and CGTP v...

Guide on Compounding Beta-Lactam Products

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Compounding Certain Beta-Lactam Products in Shortage Under ...

Latest Philips Respironics MDRs

[ Price : $8.95]

FDA reports on the latest three months of medical device reports on some Philips Respironics ventilators, BiPAP, and CPAP machines...

FDA Updates Web Page on Medtronic HeartWare Recalls

[ Price : $8.95]

FDA updates a Web page it maintains on Medtronic recalls involving its HeartWare Ventricular Assist Device system that is intended...

ORA Reorganization Notice Corrected

[ Price : $8.95]

Federal Register notice: FDA corrects a 9/28 notice entitled Statement of Organization, Functions, and Delegations of Authority th...

Zimmer Biomet New Persoa Tibis Cleared

[ Price : $8.95]

FDA clears a Zimmer Biomet 510(k) for the Persona OsseoTi Keel Tibia for cementless knee replacement.

FDA OKs Jazz sBLA for Mon./Wed./Fri. Rylaze Dosing

[ Price : $8.95]

FDA has approved a Jazz Pharmaceuticals supplemental BLA to add a Monday/Wednesday/Friday intramuscular dosing schedule for Rylaze...

Science Board to Discuss Cadmium Exposure

[ Price : $8.95]

Federal Register notice: FDA announces a 12/8 Science Board to the FDA Advisory Committee meeting that will hear research needs fo...

Gamida Cell BLA Review Extended by 3 Months

[ Price : $8.95]

FDA extends by three months the review of a Gamida Cell BLA for omidubicel for treating patients with blood cancers in need of an ...

Webinar on Rx Drug Labeling Resources

[ Price : $8.95]

FDA announces a 1/26/2023 Webinar entitled FDAs Labeling Resources for Human Prescription Drugs that will discuss new resources av...